基因组分析揭示了CD30+和CD30-外节自然杀手/T细胞淋巴瘤 (ENKTLs) 的分子特征

Xiaoying Zhang1, Ke Liang2, Haiyan Chen3

  • 1Department of Pathology, School of Basic Medical Sciences and Qilu Hospital, Shandong University, Jinan, China; Department of Pathology, Shandong Provincial Third Hospital, Shandong University, Jinan, China.

Human pathology
|August 26, 2024
PubMed
概括

这项研究揭示了外自然杀手 (NK) /T细胞淋巴瘤 (ENKTL) 的共同和独特的遗传突变,区分了CD30阳性和CD30阴性亚型. 这些发现突出了BCL10作为ENKTL治疗的潜在治疗点.